ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000571.1|Burhizin_1 # 1 # 1800 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.561	BGC0000571.1|Burhizin_1 	1	1800	-	Loose	1000	216.468	msbA	29.56	3003950	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGCGGCACGGTCTTTTTAAGACGATCTTTTTTCTGCTGGGTTGTTTGTGGACGCGCGAATGGAGAACGCGTCTTCAGCTCATCGCCGCCATTGGCTGTACCGGATGCTCGGTCGGACTCACCATTGTCTCTCCGATGCTGCTCAAGTGGCTCATCGATGGTTTGTCCGGCGCGTCGCTCTCGGCGACGAGCGTTTATCTGCTCTGCGTAGCGTACGGCGGGGCATGGTTCCTGTCGCAAGCGACGCACCGTTGCGAAGAGTATCTGTTCGTGGTGGTCAATGAGCGGATCAAACGCACGATTACGCTGAACTACGTCAGCCGAGTGCTCGGTCAGCCCGCTGCGGCATTGAGTGCTCACCAAACGGGCGCCTCCGTGAGCGAGCTCACGCGCGTACAAGACAGTGCGATGCGGGCAATTATCGGACTCTTTTGGAGCCTCGCGCCGATTTGCGTCGAAATCGTGGTCGTCGGCATCGTCGTTTGTTCGTTGTTTGGCTGGGTTTATGCAGCAGTCTTGCTGGGAATTTTGACCCTTTATCTTTACTTTAGCGTCGCGACGGCGAAGCGCTGCGAAGTGCTGCAACGCAAGAAAAACCGGGCGTCGGATCGCGCTTCGACACGACTCGTCGATACGCTCACGCATGCCGACACGGTCAAAGCGTTTTCGAATGAAGCCAGCGAACTCGCGCGGCTCAACCGTGTGTTCAAAATGCGGGCCTGGGCGAGTATCCATATCGCGCGCAAGATGGAAATCGTCGGCGCTGCGCAATTACTGATTGTCGGTATCGGGTTGACTGCGCTCACGGCGCTGGCGGGACGGGATATTTTGGCGCACCGGCTCACCATCGGCGATTTCGTGCTGTTGAACAGCTACCTGCTGCGATTCACGCTGCCGCTTAGCACGTTCGGCTATATGTTGCGGGGCATCCAGATCGGTTTATTCAATCTGTCGGAATTGCTGCATACCATCCGTGTCAGATGGCGCTTCGACCCCTTGGGTCAGCCTTTGTTCGAGCAGGCGCCGTCAATCGAATTTCGCAACGCCAGCTTTTGTCATCCGTGCGGTAGACGGGTATTGCGCCACGCGAATTTTTCGATTCCTGCCGGCGCTTTCTGTGCGCTGGTGGGCTCGAGCGGCGCGGGTAAGTCCACGCTCATCAAACTGTTACTGCGCCTATATAAGCTCGATGAGGGGCAAATCCTCATCGAAGGTCAACCGATCGAATCGTTTTCCGAATCGCAATTGCGTCAGTCGATCGGTTACGTGACACAAGAGGCGCATTTGTTGGATCGCTCAATCCGAGAAAACATTTGTTTTGCCTATCCGCAAGCTTCCGACTCGGAGCTTGAAAGCGTTATTCAGACCTGCGCGTTAACACCGGTCATCGCGGCGGCAAGCCAGGGCCTAGATACGTCGATTGGCGAGCGAGGCAACAAATTGTCAGGCGGTGAACGGCAACGTGTGGGGCTAGCTCGCGCTTTATTGCGCAATAGTCCTTTACTGTTGCTGGACGAACCGACTGCCGCACTCGATGCACACACCGAAGCGGATATCTTCAAACATCTCTATGAGCGTTATCGCCACACCACACGGCTCGTGATTGCACACCGGCTTGCCGCGATTCAGCAGGCAGACCTCATCTTGGTCATGCAAGAGGGGGCGATCGTGGAAACTGGCACGCATCGGAGTTTCTGGCGCAACAGGGCGTTTATGCCAATCTGTGGCATAAACAAGCTCATTCATCGGCAGCACGACCTGACCGCATCGATTCGGCAGAAACAGTCGATGCGTAGATGA	MRHGLFKTIFFLLGCLWTREWRTRLQLIAAIGCTGCSVGLTIVSPMLLKWLIDGLSGASLSATSVYLLCVAYGGAWFLSQATHRCEEYLFVVVNERIKRTITLNYVSRVLGQPAAALSAHQTGASVSELTRVQDSAMRAIIGLFWSLAPICVEIVVVGIVVCSLFGWVYAAVLLGILTLYLYFSVATAKRCEVLQRKKNRASDRASTRLVDTLTHADTVKAFSNEASELARLNRVFKMRAWASIHIARKMEIVGAAQLLIVGIGLTALTALAGRDILAHRLTIGDFVLLNSYLLRFTLPLSTFGYMLRGIQIGLFNLSELLHTIRVRWRFDPLGQPLFEQAPSIEFRNASFCHPCGRRVLRHANFSIPAGAFCALVGSSGAGKSTLIKLLLRLYKLDEGQILIEGQPIESFSESQLRQSIGYVTQEAHLLDRSIRENICFAYPQASDSELESVIQTCALTPVIAAASQGLDTSIGERGNKLSGGERQRVGLARALLRNSPLLLLDEPTAALDAHTEADIFKHLYERYRHTTRLVIAHRLAAIQQADLILVMQEGAIVETGTHRSFWRNRAFMPICGINKLIHRQHDLTASIRQKQSMRR	MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ	102.92	gnl|BL_ORD_ID|2242|hsp_num:0	2423		
BGC0000571.1|Burhizin_3 # 3557 # 4297 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.598	BGC0000571.1|Burhizin_3 	3557	4297	-	Loose	1200	24.6386	tetM	40.62	3000186	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGCCGCATCATTTGATGCCCCATGTATTTGGGGCCTGTTTTGCTCAGCAGATTATTTTACTCGATGTGGTGCGCGATCGGTATGCGGTGCTCACCGAGCGGCAATCGGCAGCCTTGGCCCAGCAGCTTGGGCTAAGTGATGCGCGCTTTGCTCGAGTCGAGGCGGTTCAGTCGGCCTCTATTCTGGAAGAATTAAAGCGGGCGCAGTGGATCAGCGTCACTTCCTTTGCCGAGGCGGACGCGAAGCTGAACATGTTGAGCCCGTCTCCGACAACGGGTGGAATGTCGGCCAATGGCTGGAAGTTGCCTGAGGATGCGTTCGCGCGTCGCCCCGCCTGGACCCGCATCGTCAAAGCGCTGTTCCTCTTGCGATCCGTGCACCGATGCGCCGCGCGGCAGGGACTGGCTGGGTTATTGCAACTGTGCCATCAGGCGCACCGCGAGGCCAGCCTGCGTATCGGTCTGCCCGATGATTATGCGCCCTTCGTGGACGCGCTCAATTGGGCTTGTCTGTTTTATCCCCGCTCGACCAAGTGTTTAGAGTGGTCCGTCGCGCTGACCGTGTTGTGCGCGCGTGCCGGTTTGGCGCTGAAATTGGTGATTGGCGTGCAATCCTTTCCGTTTTATGCACACGCCTGGTCGGAAGCCGGCGGGGCGGTGATTGGCGATAGCCCGCTCAGACGCAAAGAGCTCGCCGTAATTCTGGAATGTCCCCATCCGCTGCTTGACCTGTCCGTATGA	MPHHLMPHVFGACFAQQIILLDVVRDRYAVLTERQSAALAQQLGLSDARFARVEAVQSASILEELKRAQWISVTSFAEADAKLNMLSPSPTTGGMSANGWKLPEDAFARRPAWTRIVKALFLLRSVHRCAARQGLAGLLQLCHQAHREASLRIGLPDDYAPFVDALNWACLFYPRSTKCLEWSVALTVLCARAGLALKLVIGVQSFPFYAHAWSEAGGAVIGDSPLRRKELAVILECPHPLLDLSV	MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIEGNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVITNKFYSSTHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSINGELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT	38.50	gnl|BL_ORD_ID|1596|hsp_num:0	1692		
BGC0000571.1|Burhizin_4 # 4422 # 4574 # -1 # ID=1_4;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.582	BGC0000571.1|Burhizin_4 	4422	4574	-	Strict	750	21.557	tet(E)	100.0	3000173	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAACAAGCAACAACAAGAGTCGGGCCTGCTGTTGGCCGAGGAATCGCTGATGGAGCTGTGCGCGTCGTCAGAGACGCTGGGCGGTGCGGGACAGTACAAGGAAGTGGAAGCTGGCCGCTGGAGTGATCGCATTGACTCCGACGACGAATAA	MNKQQQESGLLLAEESLMELCASSETLGGAGQYKEVEAGRWSDRIDSDDE	MNRTVMMALVIIFLDAMGIGIIMPVLPALLREFVGKANVAENYGVLLALYAMMQVIFAPLLGRWSDRIGRRPVLLLSLLGATLDYALMATASVVWVLYLGRLIAGITGATGAVAASTIADVTPEESRTHWFGMMGACFGGGMIAGPVIGGFAGQLSVQAPFMFAAAINGLAFLVSLFILHETHNANQVSDELKNETINETTSSIREMISPLSGLLVVFFIIQLIGQIPATLWVLFGEERFAWDGVMVGVSLAVFGLTHALFQGLAAGFIAKHLGERKAIAVGILADGCGLFLLAVITQSWMVWPVLLLLACGGITLPALQGIISVRVGQVAQGQLQGVLTSLTHLTAVIGPLVFAFLYSATRETWNGWVWIIGCGLYVVALIILRFFHPGRVIHPINKSDVQQRI	12.35	gnl|BL_ORD_ID|152|hsp_num:0	142	True	loose hit with at least 95 percent identity pushed strict
